In line with these studies, a recent report has further demonstrated that Tim-3 on DCs instead of T cells (both CD4 and CD8 T cells) is essential for mediating the beneficial effects of anti-tumor immunity by Tim-3 blockade [27]. Here, CD8A is linked to neoplasm.